Recent Advances in Psychopharmacology of Depression *

Amsterdam J. Brunswick D. Mendels J. (1980) The clinical application of tricyclic antidepressant pharmacokinetics and plasma levels. American Journal of Psychiatry, 137, 653–662.

Åsberg M. Cronholm B. Sjoqvist F. Tuck D. (1976) Serotonin depression – a biochemical subgroup within the affective disorders. Science, 191, 478–480.

Brown W. Johnston R. Mayfield D. (1979) The 24 hour dexamethasone suppression test in a clinical setting: relationship to diagnosis, symptoms and responses to treatment. American Journal of Psychiatry, 136, 543–547.

Burrows G. Davies B. Norman T. Maguire K. Scoggins B. (1978) Should plasma level monitoring of tricyclic antidepressants be introduced in clinical practice? Communications in Psychopharmacology, 2, 393–408.

Butler P. Besser G. (1968) Pituitary-adrenal function in severe depressive illness. Lancet, 1, 1234–1236.

Carpenter W. Bunney W. (1971) Adrenal cortical activity in depressive illness. American Journal of Psychiatry, 128, 31–40.

Carroll B. (1972) Plasma cortisol levels in depression. In Depressive Illness – Some Research Studies. (eds. Davies B. Carroll B. Mowbray R. ). Charles Thomas, Illinois.

Carroll B. (1979) Prediction of treatment outcome with lithium. In Lithium: Controversies and Unresolved Issues. (eds. Cooper T. Gershon S. Kline N. Schou M. ). Excerpta Medica, Amsterdam.

Carroll B. Curtis G. Mendels J. (1976a) Neuroendocrine regulation in depression. I. Limbic system-adrenocortical dysfunction. Archives of General Psychiatry, 33, 1039–1044.

Carroll B. Curtis G. Mendels J. (1976b) Neuroendocrine regulation in depression. II. Discrimination of depressed from non-depressed patients. Archives of General Psychiatry, 33, 1051–1058.

Carroll B. Greden J. Rubin R. Haskett R. Fienberg M. Schtiengart D. (1978) Neurotransmitter mechanisms of neuroendocrine disturbances in depression. Acta Endocrinologica, Suppl. 220, 14.

Carroll B. Greden J. Fienberg M. , (1980) Neuroendocrine disturbances and the diagnosis and etiology of endogenous depression. Lancet, 1, 321–322.

Checkley S. (1979) Corticosteroid and growth hormone response to methylamphetamine in depressive illness. Psychological Medicine, 9, 107–116.

Checkley S. Crammer J. (1977) Hormone responses to methylamphetamine in depression. British Journal of Psychiatry, 131, 582–586.

Coppen A. Rao Rama V. Ruthven C. Goodwin B. Sandler M. (1979) Urinary 4 hydroxy-3-methoxyphenylglycol is not a predictor for clinical response to amitriptyline in depressive illness. Psychopharmacology, 641, 95–97.

Dunner D. Meltzer H. Fieve R. , (1978) Clinical correlates of the lithium pump. American Journal of Psychiatry, 135, 1062–1064.

Gold P. Goodwin F. (1977) Urinary Free Cortisol in Depression and Mania. Presented at the 130th Annual Meeting of the American Psychiatric Association. Toronto, Canada, May 2–6.

Gold M. Pottash A. Extein I. Sweeney D. (1980) Dexamethasone suppression tests in depression and response to treatment. Lancet, 1, 1190.

Goldberg T. (1980) Dexamethasone suppression test as indication of safe withdrawal of antidepressant therapy. Lancet, 1, 376.

Greden J. Albala A. Haskett R. James N. Goodman L. Steiner M. Carroll B. (1980) Normalisation of dexamethasone suppression test. A laboratory index of recovery from endogenous depression. Biological Psychiatry, 15, 449–459.

Hullin R. , (1978) Minimum effective plasma lithium levels for long-term preventive treatment of recurrent affective disorders. In Lithium: Controversies and Unresolved Issues. (eds, Cooper T. Gershon S. Kline N. Schou M. ). Excerpta Medica, Amsterdam.

Hullin R. Coley V. Birch N. Thomas T. Morgan D. (1979) Renal function after long-term treatment with lithium. British Medical Journal, 1, 1457–1459.

Johnson G. (In press) Endocrine dysfunction in depression. In Handbook of Endocrinology and Psychiatry. (eds. Burrows G. Beumont P. ). Elsevier/North-Holland.

Johnson G. Hunt G. Jackson D. Richards T. Kwan E. (1979) Pharmacokinetics of standard and sustained-release (Priadel) lithium carbonate preparations. Medical Journal of Australia, 2, 382.

Krieger D. (1970) Factors influencing the circadian periodicity of adrenal steroid levels. Transactions New York Academy of Science, 32, 316–328.

Maas J. W. (1975) Biogenic amines and depression. Biochemical and pharmacological separations of two types of depression. Archives of General Psychiatry, 32, 1357.

Mendels J. Frazer A. (1973) Intracellular lithium concentration and clinical response. Towards a membrane theory of depression. Journal of Psychiatric Research, 10, 9–18.

Mendlewicz J. Linkowski P. Branchey L. Weinberg U. Weitzman E. Branchey M. (1979) Abnormal 24 hour pattern of melatonin secretion in depression. Lancet, 2, 1362.

Sacchetti E. Allaria E. Negri F. Biondi P. A. Smeraldi E. Azzullo C. L. (1979) 3-Methoxy-4-hydroxyphenylglycol and primary depression: clinical and pharmacological considerations. Biological Psychiatry, 14, 473–484.

Schildkraut J. J. (1973) Norepinephrine metabolites and biochemical criteria for classifying depressive disorders and predicting responses to treatment: preliminary findings. American Journal of Psychiatry, 130, 695.

Shopsin B. Gershon S. (1971) Plasma cortisol response to dexamethasone suppression in depressed and control patients. Archives of General Psychiatry, 24, 320–326.

Stokes P. (1972) Studies on the control of adrenal cortical function in depression. In Recent Advances in the Psychobiology of the Depressive Illness, (eds. Williams T. Shield J. Katz M. ) U.S. Govt. Printing Office, Washington D.C.

Traskman L. Åsberg M. Bertilsson L. (1980) Serotonin and Noradrenaline Uptake Inhibitors in the Treatment of Depression Relationship to 5HIAA in Spinal Fluid. Presented at International Symposium on Recent Advances in the Treatment of Depression, Corfu, April, 16–18.

van Praag H. M. (1977) New evidence of serotonin-deficient depressions. Neuropsychobiology, 3, 56–63.

Vestergaard P. Amdisen A. Hansen H. Schou M. (1979) Lithium treatment and kidney function. A survey of 237 patients in long-term treatment. Acta Psychiatrica Scandinavica, 60, 504–520.

Wetterberg L. Beck-Friis J. Aperia B. Petterson U. (1979) Melatonin/cortisol ratio in depression. Lancet, 2, 1361.

Ziegler V. Co B. Biggs J. (1977) Plasma nortriptyline levels and ECG findings. American Journal of Psychiatry, 134, 441–443.